ArticleCancer drug resistance (Alhambra, Calif.)2024

Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a.

Mingyu Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.